Since injured lymphatic vessels appear to have weaker intrinsic compensatory responses to the high-sodium environment likely prevailing in a disease setting, we examined the effects of the NKCC1 inhibitor furosemide in PAN-injured and control vessels. The gene discussed is SLC12A2; the disease is polyarteritis nodosa.